Delivery Order SPE2DB22D3010-SPE2DB24FP2SD
Award Date
6/27/24
Potential Completion Date
6/28/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product QSYMIA 7.5 MG-46 MG CAPSULE 30S. The contract, valued at $1,274.90, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of the pharmaceutical product Qsymia 11.25 mg-69 mg capsules. The contract, valued at $2,228.40, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a firm fixed price pricing type. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, provides Qsymia 7.5 mg-46 mg capsules to the Defense Logistics Agency (DLA). The $1,245.70 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug QSYMIA 7.5MG-46MG 30S. The contract, valued at $1,663.14, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which serves as the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,466.30, is for the delivery of the prescription medication QSYMIA 3.75 MG-23 MG CAPSULE 30S. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of QSYMIA 7.5 MG-46 MG capsules to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $6,251.20 and a completion date of September 10, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a delivery order, with a firm fixed-price pricing type. This award is not associated with a set-aside...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,038.20 firm-fixed-price delivery order is for the supply of Qsymia 7.5 mg-46 mg capsules. The order has an ultimate completion date of August 12, 2024. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, by the Defense Logistics Agency (DLA). The award is a $1,360.17 delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued up to $999,999,999 through December 2025. The contract is for the delivery of Qsymia 7.5 mg-46 mg capsules, a prescription medication. This order does not have a set-aside designation. Amerisourcebergen, through its...
This federal contract award, valued at $6,070.08, was issued by the Department of Defense's Medical Supply Chain (also known as the Defense Logistics Agency Troop Support Medical) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the delivery of 4564800154 QSYMIA 7.5 MG-46 MG CAPSULE 30S, a prescription medication, with a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of the prescription drug QSYMIA 7.5MG-46MG 30S. The contract, which is a firm fixed price type, has a ceiling value of $1,507.20 and runs through July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...